RxDoctor Payments Data

Angelica Cifuentes

Optometrist · Miami, FLNPI 1912646415

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $47,818 of the $68,205 with a category attached, or 70.1%. 19 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 36.6% of the total. 2025 is the largest year on record at $49,592, more than ten times the $1,122 reported in 2022. Among optometrist clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$68,205in general payments, 2019–2025

Across 219 payments — averaging $311.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$25K
  • Tarsus Pharmaceuticals, Inc.$19K
  • Alcon$16K
  • Coopervision Inc.$4K
  • Johnson & Johnson Vision Care, Inc.$2K
  • Dompe US, Inc.$404
  • plus $1K from 13 others

What the payments were for

  • Consulting fees$47,81870%
  • Speaking & faculty fees$5,9709%
  • Travel & lodging$5,8179%
  • Food & beverage$8,59213%
  • Education$70%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$68,205 in reported general payments places this provider in the 95th percentile of 3,166 optometrist providers in Florida.

See all optometrist providers in Florida

Other optometrist in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →